Developing a new drug delivery technologies and utilizing them in product development is critical for pharmaceutical industries to isurvive, regardless of their size. As a drug nears the end of its patent life, it is common for pharmaceutical manufacturers to develop a given drug entity in a new and improved dosage form. A new dosage form allows a manufacturer to extend market exclusivity, unique product differentiation, value-added product line extension, and extend patent protection, while offering its patient population a more convenient dosage form. This leads to increased revenue, while also targeting under-served and under-treated patient ipopulations. Marketers build a better brand and company image when they offer a unique easier-to-take form that satisfies the need of an underserved patient population.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Ms. Gulfisha Shaikh (M. Pharm-P'ceutics), Mrs. Raksha Goswami (M. Pharm-P'cology), Mrs. Apoorva Tiwari (M. Pharm-QA), Mr. Deepak Kumawat (M. Pharm-P'chemistry) are working as Asst. Prof. in Oriental University, Indore
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Textbook on Development and Evaluation of Liquid Dosage Form | Gulfisha Shaikh (u. a.) | Taschenbuch | Englisch | 2021 | LAP LAMBERT Academic Publishing | EAN 9786203862157 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. Artikel-Nr. 120211421
Anzahl: 5 verfügbar